翻訳と辞書 |
Biota Holdings : ウィキペディア英語版 | Biota Holdings Biota was an Australian antiviral drug development company listed on the Australian Stock Exchange (ASX:BTA). In 1989 Biota discovered the drug Zanamivir, which acts as a neuraminidase inhibitor for the treatment and prevention of influenza. This drug is licensed to GlaxoSmithKline and marketed as Relenza. In November 2012, ''Biota Holdings Limited'' merged with American company ''Nabi Biopharmaceuticals'' to form Biota Pharmaceuticals. The combined company has its headquarters in the U.S. and is now listed on the NASDAQ under the abbreviated code BOTA. ==External links==
* (Biota Pharmaceuticals website )
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Biota Holdings」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|